What this means
This study gave one oral dose of a labeled drug to healthy male volunteers. It aimed to see how the body moves the drug, how it is processed, and how safe it is.
Plain-English summary written by an AI model from the registry listing.
- Status
- Completed
- Who can join
- Ages 18–55
- Where
- 1 site, including Wisconsin
The science
- Registered title
- Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration
- Trial ID
- NCT06425003 ↗
- Phase
- PHASE 1
- Study type
- interventional
- Conditions
- Healthy Volunteer
- What is tested
- [14C] ABBV-CLS-7262
- Sponsor
- Calico Life Sciences LLC
- Ages
- 18 Years to 55 Years
- Dates
- First posted May 22, 2024 · updated Jul 19, 2024
Registry summary
The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of [14C] ABBV-CLS-7262 in healthy, male volunteers following administration of a single oral dose.
Sites (1)
- Fortrea Clinical Research Unit Inc., Madison, Wisconsin, United States